U.S. flag

An official website of the United States government

NM_000388.4(CASR):c.190A>G (p.Asn64Asp) AND Neonatal severe primary hyperparathyroidism

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
May 7, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003225225.1

Allele description [Variation Report for NM_000388.4(CASR):c.190A>G (p.Asn64Asp)]

NM_000388.4(CASR):c.190A>G (p.Asn64Asp)

Gene:
CASR:calcium sensing receptor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3q21.1
Genomic location:
Preferred name:
NM_000388.4(CASR):c.190A>G (p.Asn64Asp)
HGVS:
  • NC_000003.12:g.122257085A>G
  • NG_009058.2:g.78418A>G
  • NM_000388.4:c.190A>GMANE SELECT
  • NM_001178065.2:c.190A>G
  • NP_000379.3:p.Asn64Asp
  • NP_001171536.2:p.Asn64Asp
  • NC_000003.11:g.121975932A>G
  • NM_000388.3:c.190A>G
Protein change:
N64D
Links:
dbSNP: rs2107627423
NCBI 1000 Genomes Browser:
rs2107627423
Molecular consequence:
  • NM_000388.4:c.190A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001178065.2:c.190A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Neonatal severe primary hyperparathyroidism
Synonyms:
Neonatal severe hyperparathyroidism
Identifiers:
MONDO: MONDO:0009397; MedGen: C1832615; Orphanet: 417; OMIM: 239200

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003921998Victorian Clinical Genetics Services, Murdoch Childrens Research Institute
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(May 7, 2021)
maternalclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedmaternalyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Victorian Clinical Genetics Services, Murdoch Childrens Research Institute, SCV003921998.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

0103 - Dominant negative, loss of function and gain of function are known mechanisms of disease in this gene and are associated with CASR-related disease (OMIM). Truncating variants predicted to undergo nonsense-mediated decay, and missense variants with either a dominant negative or loss of function effect on protein function, have been reported to cause hypocalciuric hypercalcemia, type I (MIM#145980), and neonatal hyperparathyroidism (MIM#239200). Missense variants that have a gain of function effect on protein activity, have been reported to cause hypocalcemia, with or without Barrter syndrome (MIM#601198) (OMIM, PMID: 22422767, PMID: 26646938, PMID: 16649980). (I) 0108 - This gene is associated with both recessive and dominant disease. Recessive disease is caused by biallelic loss of function variants, and results in neonatal hyperparathyroidism (MIM#239200) (OMIM, PMID: 22422767, PMID: 26646938). (I) 0115 - Variants in this gene are known to have variable expressivity. Members of the same family have been reported to exhibit either hypercalcemia, hypocalciuric or hypercalciuric (OMIM). (I) 0200 - Variant is predicted to result in a missense amino acid change from asparagine to aspartic acid. (I) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0502 - Missense variant with conflicting in silico predictions and uninformative conservation. (I) 0600 - Variant is located in the annotated ligand binding domain (PDB, NCBI). Protein modelling has indicated that an agonist is expected to form a hydrogen bond with this residue (PMID: 32387992). (I) 0705 - No comparable missense variants have previous evidence for pathogenicity. Nearby missense variants (p.Arg66Cys, p.Arg66His, p.Cys60Tyr) have been reported as pathogenic and in patients with recessive disease (ClinVar, PMID: 33179231). (I) 0807 - This variant has no previous evidence of pathogenicity. (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1101 - Very strong and specific phenotype match for this individual. (SP) 1205 - This variant has been shown to be maternally inherited (by trio analysis). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1maternalyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Dec 24, 2023